Effects of celecoxib. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy13

Nipples HT29 Cells Cell Line, Tumor Gastric Mucosa Tumor Cells, Cultured Sclera Intestinal Mucosa Choroid Enterocytes Caco-2 Cells Body Fluids Bile Ducts, Intrahepatic HCT116 Cells

Organisms9

Mice, Nude Rats, Inbred F344 Rats, Sprague-Dawley Salvia miltiorrhiza Rats, Wistar Mice, Inbred C57BL Mice, Inbred BALB C Mice, Hairless Rats, Inbred WF

Diseases51

Gastrointestinal Diseases Osteoarthritis Adenomatous Polyposis Coli Colonic Neoplasms Colorectal Neoplasms Lung Neoplasms Adenoma Osteoarthritis, Knee Nociceptive Pain Adenocarcinoma Disease Models, Animal Stomach Ulcer Neovascularization, Pathologic Arthritis, Rheumatoid Precancerous Conditions Cholangiocarcinoma Intestinal Polyps Hand-Foot Syndrome Carcinoma, Non-Small-Cell Lung Kashin-Beck Disease Prostatic Neoplasms Gastrointestinal Hemorrhage Edema Peptic Ulcer Hemorrhage Adenomatous Polyps Osteoarthritis, Hip Neointima Urinary Bladder Neoplasms Disease Progression Leukemic Infiltration Cardiovascular Diseases Arthritis, Experimental Stomach Neoplasms Mammary Neoplasms, Animal Carcinoma, Squamous Cell Drug Hypersensitivity Peritoneal Fibrosis Bronchial Diseases Arthritis Head and Neck Neoplasms Mucositis Glioma Pain Hyperplasia Inflammation Mammary Neoplasms, Experimental Pain, Postoperative Spondylitis, Ankylosing Nephrosis Bile Duct Neoplasms Skin Diseases

Chemicals and Drugs101

Pyrazoles Sulfonamides Cyclooxygenase 2 Inhibitors Cyclooxygenase Inhibitors Cyclooxygenase 2 Anti-Inflammatory Agents, Non-Steroidal Prostaglandin-Endoperoxide Synthases Dinoprostone Sulfones Lactones Diclofenac Cyclooxygenase 1 Isoenzymes Naproxen Anticarcinogenic Agents Ibuprofen Membrane Proteins Thiazines Antineoplastic Agents Aspirin Etodolac Prostaglandins Arachidonate 5-Lipoxygenase Azoxymethane Lipoxygenase Inhibitors Acetaminophen Indomethacin Placebos Emulsifying Agents Nitrobenzenes 3-Phosphoinositide-Dependent Protein Kinases Dipyrone Analgesics Ki-67 Antigen Carcinogens Phenylenediamines Eicosanoids Butylhydroxybutylnitrosamine Flurbiprofen Vascular Endothelial Growth Factor A Homoarginine Caspases, Initiator 6-Ketoprostaglandin F1 alpha Proto-Oncogene Proteins c-akt Polyglycolic Acid Analgesics, Non-Narcotic Leukotriene E4 Povidone Pyrroles Lipoxins Acetone Methylcellulose Anti-Inflammatory Agents Sulindac Powders Thromboxane B2 Cholagogues and Choleretics RNA, Messenger Caspase 3 Delayed-Action Preparations Heptanoic Acids Capsules Shab Potassium Channels Endostatins Ursodeoxycholic Acid Caspases Cyclin-Dependent Kinase Inhibitor p21 Hydroxyurea Organic Chemicals Aminobiphenyl Compounds Transcription Factor CHOP Angiogenesis Inhibitors Melanins Drug Carriers Interleukin-1beta Leupeptins Camptothecin Prostaglandins A Hydroxyprostaglandin Dehydrogenases Fenretinide Butylated Hydroxytoluene Isoxazoles Benzothiazoles Epoprostenol Quinazolines Omeprazole Protein-Serine-Threonine Kinases Taxoids Luteinizing Hormone, beta Subunit KCNQ Potassium Channels Emodin Organophosphates Methylnitrosourea 9,10-Dimethyl-1,2-benzanthracene Proto-Oncogene Proteins c-bcl-2 Purinones Fluorouracil Thioacetamide Enzyme Inhibitors Prostaglandin Antagonists NF-kappa B

Analytical, Diagnostic and Therapeutic Techniques and Equipment44

Powder Diffraction Double-Blind Method Treatment Outcome Drug Administration Schedule Xenograft Model Antitumor Assays Drug Incompatibility Chemoprevention Drug Therapy, Combination Placebos Administration, Oral Blotting, Western Antineoplastic Combined Chemotherapy Protocols Pain Measurement Immunohistochemistry Disease Models, Animal Technology, Pharmaceutical Maximum Tolerated Dose Chronotherapy Inhibitory Concentration 50 In Situ Nick-End Labeling Pilot Projects Analysis of Variance Delayed-Action Preparations Single-Blind Method Reverse Transcriptase Polymerase Chain Reaction Area Under Curve Cross-Over Studies Immunoenzyme Techniques Calorimetry, Differential Scanning Combined Modality Therapy Bronchoalveolar Lavage Drug Evaluation, Preclinical Drug Carriers Arthritis, Experimental Models, Economic Drug Screening Assays, Antitumor Risk Factors Follow-Up Studies Adverse Drug Reaction Reporting Systems Randomized Controlled Trials as Topic Neoplasm Transplantation Mammary Neoplasms, Experimental Radiotherapy Orthodontic Appliances

Psychiatry and Psychology1

Phenomena and Processes21

Dose-Response Relationship, Drug Apoptosis Drug Synergism Cell Proliferation Cell Survival Time Factors Biological Availability Drug Antagonism Maximum Tolerated Dose Inhibitory Concentration 50 Cell Division Drug Interactions Area Under Curve Cell Cycle Signal Transduction G0 Phase Solubility Food-Drug Interactions Pain Gene Expression Regulation, Neoplastic G1 Phase

Disciplines and Occupations3

Chemistry, Pharmaceutical Immunohistochemistry Technology, Pharmaceutical

Technology, Industry, Agriculture3

Technology, Pharmaceutical Polyglycolic Acid Povidone

Information Science1

Adverse Drug Reaction Reporting Systems

Health Care14

Double-Blind Method Treatment Outcome Economics, Pharmaceutical Pilot Projects Analysis of Variance Single-Blind Method Area Under Curve Cross-Over Studies Models, Economic Drug Utilization Review Risk Factors Follow-Up Studies Adverse Drug Reaction Reporting Systems Randomized Controlled Trials as Topic

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Health Care Geographicals

Pyrazoles Sulfonamides Cyclooxygenase 2 Inhibitors Cyclooxygenase Inhibitors Cyclooxygenase 2 Anti-Inflammatory Agents, Non-Steroidal Prostaglandin-Endoperoxide Synthases Dinoprostone Sulfones Lactones Diclofenac Cyclooxygenase 1 Isoenzymes Naproxen Anticarcinogenic Agents Gastrointestinal Diseases Osteoarthritis Dose-Response Relationship, Drug Powder Diffraction Nipples Ibuprofen Membrane Proteins Apoptosis Thiazines HT29 Cells Cell Line, Tumor Antineoplastic Agents Double-Blind Method Adenomatous Polyposis Coli Aspirin Drug Synergism Cell Proliferation Etodolac Colonic Neoplasms Prostaglandins Treatment Outcome Colorectal Neoplasms Drug Administration Schedule Arachidonate 5-Lipoxygenase Xenograft Model Antitumor Assays Azoxymethane Lipoxygenase Inhibitors Drug Incompatibility Chemoprevention Drug Therapy, Combination Mice, Nude Acetaminophen Lung Neoplasms Indomethacin Placebos Administration, Oral Blotting, Western Emulsifying Agents Nitrobenzenes Economics, Pharmaceutical Adenoma Antineoplastic Combined Chemotherapy Protocols Cell Survival Pain Measurement Osteoarthritis, Knee 3-Phosphoinositide-Dependent Protein Kinases Dipyrone Chemistry, Pharmaceutical Immunohistochemistry Analgesics Nociceptive Pain Ki-67 Antigen Adenocarcinoma Disease Models, Animal Stomach Ulcer Carcinogens Phenylenediamines Neovascularization, Pathologic Time Factors Arthritis, Rheumatoid Rats, Inbred F344 Eicosanoids Precancerous Conditions Technology, Pharmaceutical Rats, Sprague-Dawley Cholangiocarcinoma Butylhydroxybutylnitrosamine Intestinal Polyps Biological Availability Flurbiprofen Vascular Endothelial Growth Factor A Homoarginine Quebec Caspases, Initiator 6-Ketoprostaglandin F1 alpha Drug Antagonism Hand-Foot Syndrome Proto-Oncogene Proteins c-akt Maximum Tolerated Dose Polyglycolic Acid Carcinoma, Non-Small-Cell Lung Gastric Mucosa Analgesics, Non-Narcotic Leukotriene E4 Chronotherapy

No FAQ available that match "effects of celecoxib"